This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Search results
From Proteopedia
You searched for Mcinnes,_R.R.
There is no page with the exact title "Mcinnes,_R.R.". The search results for "Mcinnes,_R.R." are displayed below. You can create a page titled Mcinnes,_R.R. (by clicking on the red link).
For more information about searching Proteopedia, see Help.
To exclude pages titled with 4-character PDB codes, use the checkbox "only Human created pages" at the bottom of this page.
Showing below up to 20 results starting with #1.
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
Article title matches
- Category:Mcinnes C (40 bytes)
1: List of pages with the keyword Mcinnes C - Category:Mcinnes, C (41 bytes)
1: List of pages with the keyword Mcinnes, C - Category:McInnes, C (41 bytes)
1: List of pages with the keyword McInnes, C - Category:Mcinnes, R R (43 bytes)
1: List of pages with the keyword Mcinnes, R R - Category:McInnes, S J (43 bytes)
1: List of pages with the keyword McInnes, S J - Category:McInnes SJ (41 bytes)
1: List of pages with the keyword McInnes SJ - Category:Mcinnes RR (41 bytes)
1: List of pages with the keyword Mcinnes RR - Category:McInnes C (40 bytes)
1: List of pages with the keyword McInnes C
Page text matches
- 1ol2 (7,619 bytes)
2: ==Cyclin A binding groove inhibitor H-Arg-Arg-Leu-Asn-(p-F-Phe)-NH2==
3: ...aption='[[1ol2]], [[Resolution|resolution]] 2.60Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=1OL2 FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.6Å</td></tr> - 1ol1 (7,671 bytes)
2: ==Cyclin A binding groove inhibitor H-Cit-Cit-Leu-Ile-(p-F-Phe)-NH2==
3: ...aption='[[1ol1]], [[Resolution|resolution]] 2.90Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=1OL1 FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.9Å</td></tr> - 2uue (7,808 bytes)
2: ...Iterative Design of Cyclin Binding Groove Inhibitors==
3: ...aption='[[2uue]], [[Resolution|resolution]] 2.06Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=2UUE FirstGlance]. <br>
6: ...ion, [[Resolution|Resolution]] 2.06Å</td></tr> - 1okw (7,675 bytes)
2: ==Cyclin A binding groove inhibitor Ac-Arg-Arg-Leu-Asn-(m-Cl-Phe)-NH2==
3: ...aption='[[1okw]], [[Resolution|resolution]] 2.50Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=1OKW FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.5Å</td></tr> - 1urc (7,714 bytes)
2: ==Cyclin A binding groove inhibitor Ace-Arg-Lys-Leu-Phe-Gly==
3: ...aption='[[1urc]], [[Resolution|resolution]] 2.60Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=1URC FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.6Å</td></tr> - 2c5n (7,218 bytes)
2: ...o Active And Inactive Cdk2 Provides Insights For Drug Design==
3: ...aption='[[2c5n]], [[Resolution|resolution]] 2.10Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=2C5N FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.1Å</td></tr> - 2c5x (7,245 bytes)
2: ...o Active And Inactive Cdk2 Provides Insights For Drug Design==
3: ...aption='[[2c5x]], [[Resolution|resolution]] 2.90Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=2C5X FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.9Å</td></tr> - 2c5v (7,628 bytes)
2: ...o Active And Inactive Cdk2 Provides Insights For Drug Design==
3: ...aption='[[2c5v]], [[Resolution|resolution]] 2.90Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=2C5V FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.9Å</td></tr> - 2c5y (7,246 bytes)
2: ...O ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN==
3: ...aption='[[2c5y]], [[Resolution|resolution]] 2.25Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=2C5Y FirstGlance]. <br>
6: ...ion, [[Resolution|Resolution]] 2.25Å</td></tr> - 2c5o (7,187 bytes)
2: ...o Active And Inactive Cdk2 Provides Insights For Drug Design==
3: ...aption='[[2c5o]], [[Resolution|resolution]] 2.10Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=2C5O FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.1Å</td></tr> - 1aos (2,786 bytes)
2: ==HUMAN ARGININOSUCCINATE LYASE==
3: ...aption='[[1aos]], [[Resolution|resolution]] 4.20Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=1AOS FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 4.2Å</td></tr> - 1okv (7,547 bytes)
2: ==Cyclin A binding groove inhibitor H-Arg-Arg-Leu-Ile-Phe-NH2==
3: ...aption='[[1okv]], [[Resolution|resolution]] 2.40Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=1OKV FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.4Å</td></tr> - 1pw2 (6,759 bytes)
2: ==APO STRUCTURE OF HUMAN CYCLIN-DEPENDENT KINASE 2==
3: ...aption='[[1pw2]], [[Resolution|resolution]] 1.95Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=1PW2 FirstGlance]. <br>
6: ...ion, [[Resolution|Resolution]] 1.95Å</td></tr> - 1pxi (7,022 bytes)
2: ...TH THE INHIBITOR 4-(2,5-Dichloro-thiophen-3-yl)-pyrimidin-2-ylamine==
3: ...aption='[[1pxi]], [[Resolution|resolution]] 1.95Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=1PXI FirstGlance]. <br>
6: ...ion, [[Resolution|Resolution]] 1.95Å</td></tr> - 1pxj (7,027 bytes)
2: ...ITH THE INHIBITOR 4-(2,4-Dimethyl-thiazol-5-yl)-pyrimidin-2-ylamine==
3: ...aption='[[1pxj]], [[Resolution|resolution]] 2.30Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=1PXJ FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.3Å</td></tr> - 1pxk (7,075 bytes)
2: ...hyl-thiazol-5-yl)pyrimidin-2-yl]-N'-hydroxyiminoformamide==
3: ...aption='[[1pxk]], [[Resolution|resolution]] 2.80Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=1PXK FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.8Å</td></tr> - 1pxl (7,087 bytes)
2: ...-Dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-(4-trifluoromethyl-phenyl)-amine==
3: ...aption='[[1pxl]], [[Resolution|resolution]] 2.50Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=1PXL FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.5Å</td></tr> - 1pxm (7,483 bytes)
2: ... THE INHIBITOR 3-[4-(2,4-Dimethyl-thiazol-5-yl)-pyrimidin-2-ylamino]-phenol==
3: ...aption='[[1pxm]], [[Resolution|resolution]] 2.53Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=1PXM FirstGlance]. <br>
6: ...ion, [[Resolution|Resolution]] 2.53Å</td></tr> - 1pxn (7,524 bytes)
2: ...ITOR 4-[4-(4-Methyl-2-methylamino-thiazol-5-yl)-pyrimidin-2-ylamino]-phenol==
3: ...aption='[[1pxn]], [[Resolution|resolution]] 2.50Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=1PXN FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.5Å</td></tr> - 1pxo (7,531 bytes)
2: ...mino-4-methyl-thiazol-5-yl)-pyrimidin-2-yl]-(3-nitro-phenyl)-amine==
3: ...aption='[[1pxo]], [[Resolution|resolution]] 1.96Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=1PXO FirstGlance]. <br>
6: ...ion, [[Resolution|Resolution]] 1.96Å</td></tr>
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
You may also try
